Perhaps checking patients for blood calcitonin levels is a good place to start.
According to Daniel Bradbury and Orville Kolterman, who answered questions during AMLN CC, calcitonin levels are being measured from baseline in DURATION-5 following the liraglutide panel, and they might measure levels also from previous DURATION trials.